1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with mk 287 in 3 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (mk 287) | Trials (mk 287) | Recent Studies (post-2010) (mk 287) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 6 | 0 | 0 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | mk 287 (IC50) |
|---|---|---|---|
| Platelet-activating factor receptor | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvaro, RF; Chiu, SH; Rosegay, A | 1 |
| Fisher, AL; Gilbert, JD; Morris, MJ | 1 |
| Alberts, AW; Bach, TJ; Chabala, JC; Hwang, SB; Lam, MH; Luell, S; MacIntyre, DE; Meuer, R; Sahoo, SP; Szalkowski, DM | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and mk 287
| Article | Year |
|---|---|
Determination of enantiomeric concentrations of a 2,5-diaryltetrahydrofuran (L-668,750), a platelet-activating factor receptor antagonist, in rat plasma using a chiral alpha 1-acid glycoprotein high-performance liquid chromatographic column.
Topics: Animals; Chromatography, High Pressure Liquid; Furans; Male; Orosomucoid; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Spectrophotometry, Ultraviolet; Stereoisomerism | 1992 |
Determination of MK-287, a new platelet-activating factor antagonist, in plasma and serum by gas chromatography chemical ionization mass spectrometry.
Topics: Furans; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation Inhibitors; Radioimmunoassay | 1991 |
MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Topics: Administration, Oral; Animals; Binding, Competitive; Blood Platelets; Bronchoconstriction; Furans; Guinea Pigs; Humans; Kinetics; Lung; Membranes; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sensitivity and Specificity; Tritium | 1993 |